The North America synthetic biology market is expected to grow from US$ 4,313.62 million in 2021 to US$ 15,223.61 million by 2028; it is estimated to grow at a CAGR of 19.7% from 2021 to 2028.
Synthetic Biology Market Sees Significant Growth in North America
The field of synthetic biology is rapidly expanding, offering diverse applications across the chemicals, agriculture, pharmaceuticals, and energy industries. A thriving ecosystem of startups is driving this market growth, providing essential gene synthesis products and services.
For instance, companies like Benchling offer cutting-edge CAD tools for biological design, while GenScript specializes in gene synthesis. Ginkgo Bioworks is a key player in organism engineering, and Transcriptic provides cloud lab and automation solutions to streamline research. Even consumer products are emerging, as seen with Glowee.
Despite the initial challenges posed by the COVID-19 pandemic, the bioeconomy experienced a significant acceleration in the first half of 2020. This surge is evident in the investment landscape: 56 synthetic biology businesses collectively raised over US$3 billion in equity financing during that period, a substantial increase compared to the US$1.9 billion raised by 65 companies in the same timeframe in 2019.
This influx of capital is fueling innovation, particularly in the biopharma sector. A new generation of biopharma companies is leveraging synthetic biology to advance cell treatments, gene therapy, and early cancer detection. The increasing investment and demand for novel techniques are collectively driving the expansion of the North America synthetic biology market, especially in North America.
With continuous advancements and new technologies, vendors are well-positioned to attract new customers and expand their reach into emerging markets. This strong momentum is expected to propel the North America synthetic biology market to a notable Compound Annual Growth Rate (CAGR) over the forecast period.
North America Synthetic Biology Market Segmentation Analysis
The North America synthetic biology market is segmented by product, technology, application, and country to provide a comprehensive industry outlook.
North America synthetic biology market By Product:
- Enzymes
- Chassis Organisms
- Oligonucleotides (Dominating segment in 2020; expected to be the fastest-growing)
- Xeno-Nucleic Acids
North America synthetic biology market By Technology:
- Measurement & Modeling
- Cloning & Sequencing
- Genome Engineering (Projected to be the fastest-growing segment)
- Gene Synthesis (Leading segment in 2020)
- Nanotechnology
- Others
North America synthetic biology market By Application:
- Medical Applications (Dominating segment in 2020; anticipated to grow at the highest rate)
- Industrial Applications
- Food & Agriculture
- Environmental Applications
- Others
North America synthetic biology market By Country:
- United States
- Canada
- Mexico
North America synthetic biology market Key Players
Prominent companies driving the North America synthetic biology market include:
- Agilent Technologies, Inc.
- Amyris
- Codexis
- GenScript Biotech Corporation
- Integrated DNA Technologies
- Merck KGaA
- New England Biolabs
- Novozymes A/S
- Thermo Fisher Scientific
- Twist Bioscience
This segmentation highlights the market's structure, growth trends, and key industry players shaping the synthetic biology landscape in North America.
North America synthetic biology market Strategic Insights
Strategic insights for the North America Synthetic Biology provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
North America synthetic biology market Regional Insights
The geographic scope of the North America Synthetic Biology refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
The North America synthetic biology market is expected to grow from US$ 4,313.62 million in 2021 to US$ 15,223.61 million by 2028; it is estimated to grow at a CAGR of 19.7% from 2021 to 2028.
Synthetic Biology Market Sees Significant Growth in North America
The field of synthetic biology is rapidly expanding, offering diverse applications across the chemicals, agriculture, pharmaceuticals, and energy industries. A thriving ecosystem of startups is driving this market growth, providing essential gene synthesis products and services.
For instance, companies like Benchling offer cutting-edge CAD tools for biological design, while GenScript specializes in gene synthesis. Ginkgo Bioworks is a key player in organism engineering, and Transcriptic provides cloud lab and automation solutions to streamline research. Even consumer products are emerging, as seen with Glowee.
Despite the initial challenges posed by the COVID-19 pandemic, the bioeconomy experienced a significant acceleration in the first half of 2020. This surge is evident in the investment landscape: 56 synthetic biology businesses collectively raised over US$3 billion in equity financing during that period, a substantial increase compared to the US$1.9 billion raised by 65 companies in the same timeframe in 2019.
This influx of capital is fueling innovation, particularly in the biopharma sector. A new generation of biopharma companies is leveraging synthetic biology to advance cell treatments, gene therapy, and early cancer detection. The increasing investment and demand for novel techniques are collectively driving the expansion of the North America synthetic biology market, especially in North America.
With continuous advancements and new technologies, vendors are well-positioned to attract new customers and expand their reach into emerging markets. This strong momentum is expected to propel the North America synthetic biology market to a notable Compound Annual Growth Rate (CAGR) over the forecast period.
North America Synthetic Biology Market Segmentation Analysis
The North America synthetic biology market is segmented by product, technology, application, and country to provide a comprehensive industry outlook.
North America synthetic biology market By Product:
- Enzymes
- Chassis Organisms
- Oligonucleotides (Dominating segment in 2020; expected to be the fastest-growing)
- Xeno-Nucleic Acids
North America synthetic biology market By Technology:
- Measurement & Modeling
- Cloning & Sequencing
- Genome Engineering (Projected to be the fastest-growing segment)
- Gene Synthesis (Leading segment in 2020)
- Nanotechnology
- Others
North America synthetic biology market By Application:
- Medical Applications (Dominating segment in 2020; anticipated to grow at the highest rate)
- Industrial Applications
- Food & Agriculture
- Environmental Applications
- Others
North America synthetic biology market By Country:
- United States
- Canada
- Mexico
North America synthetic biology market Key Players
Prominent companies driving the North America synthetic biology market include:
- Agilent Technologies, Inc.
- Amyris
- Codexis
- GenScript Biotech Corporation
- Integrated DNA Technologies
- Merck KGaA
- New England Biolabs
- Novozymes A/S
- Thermo Fisher Scientific
- Twist Bioscience
This segmentation highlights the market's structure, growth trends, and key industry players shaping the synthetic biology landscape in North America.
North America synthetic biology market Strategic Insights
Strategic insights for the North America Synthetic Biology provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
North America synthetic biology market Regional Insights
The geographic scope of the North America Synthetic Biology refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
